NEW YORK (GenomeWeb News) – Molecular Detection today said that it has signed an agreement with Dutch firm Westburg BV to be the exclusive distributor of the firm's Detect-Ready MRSA panel in the Benelux region.
The Wayne, Pa.-based firm also said that the real-time PCR-based test has been CE-Marked for detection of both methicillin-resistant Staphylococcus aureus and methicillin-sensitive S, aureus. It said that the screening test enables physicians to distinguish the two types of infections.
"We anticipate launch in the Benelux region shortly, at which time our Detect-Ready MRSA panel will be available in 10 markets worldwide," David Wilson, MDI's VP for commercial operations, Europe, said in a statement.
The Detect-Ready MRSA panel is currently sold in the UK, Germany, Ireland, Switzerland, Spain, Austria, and Australia.
Financial and other terms of the agreement were not disclosed.